Filing Details

Accession Number:
0001666071-19-000104
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-28 17:03:35
Reporting Period:
2019-08-26
Accepted Time:
2019-08-28 17:03:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1666071 Cardlytics Inc. CDLX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1617486 D. Scott Grimes C/O Cardlytics, Inc.
675 Ponce De Leon Avenue Ne, Suite 6000
Atlanta GA 30308
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-08-26 2,500 $33.42 601,940 No 4 S Direct
Common Stock Disposition 2019-08-26 7,500 $34.25 594,440 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Performance Stock Unit Acquisiton 2019-08-26 78,750 $0.00 78,750 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
78,750 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 800 Indirect By immediate family member
Common Stock 194,112 Indirect See Footnote
Footnotes
  1. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 5, 2018, as amended May 14, 2019.
  2. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $32.87 to $33.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  3. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $33.87 to $34.60, inclusive.
  4. The reportable securities are held by the 2013 Scott Grimes GRAT UAD (the "GRAT"). The Reporting Person is the trustee of the GRAT.
  5. Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  6. On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the first tranche of the PSU to be awarded, which shares are reflected in Column 5 above. Fifty percent (50%) of the shares subject to the first tranche of the PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the first tranche of the PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the first tranche of the PSU will vest 12 months after the Certification. The PSU has not yet settled.